Another pharma megamerger: AbbVie buys Allergan for $63 billion

Erika Beras Jun 25, 2019
HTML EMBED:
COPY
PHILIPPE HUGUEN/AFP/Getty Images

Another pharma megamerger: AbbVie buys Allergan for $63 billion

Erika Beras Jun 25, 2019
PHILIPPE HUGUEN/AFP/Getty Images
HTML EMBED:
COPY

Earlier this year, Bristol-Myers Squibb announced it was buying Celgene for $74 billion. Now AbbVie, which makes popular drug Humira, has entered into an agreement to pay about $63 billion for Allergan, the manufacturer of Botox. What’s in it for both companies?

Click the audio player above to hear the full story.

There’s a lot happening in the world.  Through it all, Marketplace is here for you. 

You rely on Marketplace to break down the world’s events and tell you how it affects you in a fact-based, approachable way. We rely on your financial support to keep making that possible. 

Your donation today powers the independent journalism that you rely on. For just $5/month, you can help sustain Marketplace so we can keep reporting on the things that matter to you.  

Need some Econ 101?

Our new Marketplace Crash Course is here to help. Sign-up for free, learn at your own pace.